Skip to main content
PMC home page
The Journal of Hygiene logoLink to The Journal of Hygiene
. 1982 Jun;88(3):519–528. doi: 10.1017/s0022172400070376

Characterization of measles virus-specific antibodies in sera from patients with chronic active hepatitis.

K E Christie, C Endresen, G Haukenes
PMCID: PMC2134109  PMID: 7045218

Abstract

Measles virus-specific antibodies in sera from patients with HBsAg-negative chronic active hepatitis and raised antibody titres against measles virus, have been examined by crossed immunoelectrophoresis. The immunoprecipitates were further analysed by SDS-polyacrylamide gel electrophoresis. Five measles virus-specific precipitation lines were demonstrated using measles virus-infected cells solubilized with Triton X-100. The three major precipitation lines were analysed by SDS-PAGE and contained the virus polypeptides: nucleoprotein, NP (MW approximately 60 000); haemoagglutinin, H (MW approximately 80 000) and fusion protein F1 (MW approximately 40 000). Considerably higher amounts of antibodies against these three virus polypeptides were demonstrated in the patient sera than in sera from healthy controls. By SDS-PAGE analysis of radiolabelled immune complexes adsorbed to Sepharose-protein A, antibodies against five measles virus polypeptides: NP, H, F1, P protein (MW approximately 70 000) and matrix protein, M (MW approximately 37 000) were demonstrated in the patient sera.

Full text

PDF
528-2

Images in this article

528-1Plate 1
on p.528-1
528-2Plate 2
on p.528-2
528-2Plate 3
on p.528-2
528-2Plate 4
on p.528-2

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beck H. W., Clausen J. An epidemiological study on paramyxovirus antibody titers in multiple sclerosis, systemic lupus erythematosus, and rheumatoid arthritis. Zentralbl Bakteriol Orig A. 1977 Aug;238(4):431–443. [PubMed] [Google Scholar]
  2. Bonner W. M., Laskey R. A. A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels. Eur J Biochem. 1974 Jul 1;46(1):83–88. doi: 10.1111/j.1432-1033.1974.tb03599.x. [DOI] [PubMed] [Google Scholar]
  3. Cendrowski W., Niedzielska K. Multiple sclerosis: etiologic and diagnostic significance of measles virus antibodies in the cerebrospinal fluid and serum. Schweiz Arch Neurol Neurochir Psychiatr. 1974;114(2):215–228. [PubMed] [Google Scholar]
  4. Christie K. E., Haukenes G. Measles virus specific precipitins in sera from patients with chronic active hepatitis. Scand J Infect Dis. 1979;11(2):99–106. doi: 10.3109/inf.1979.11.issue-2.01. [DOI] [PubMed] [Google Scholar]
  5. Closs O., Haukenes G., Blomhoff J. P., Gjone E. High titres of antibodies against rubella and morbilli virus in patients with chronic hepatitis. Scand J Gastroenterol. 1973;8(6):523–528. [PubMed] [Google Scholar]
  6. Closs O., Haukenes G., Gjone E., Blomhoff J. P. Raised antibody titres in chronic liver disease. Lancet. 1971 Nov 27;2(7735):1202–1203. doi: 10.1016/s0140-6736(71)90520-4. [DOI] [PubMed] [Google Scholar]
  7. De Groote J. Classification of Chronic Hepatitis. Ann Clin Res. 1976 Jun;8(3):130–138. [PubMed] [Google Scholar]
  8. Eddleston A. L., Williams R. The role of immunological mechanisms in chronic hepatitis. Ann Clin Res. 1976 Jun;8(3):162–173. [PubMed] [Google Scholar]
  9. Galbraith R. M., Eddleston A. L., Williams R., Webster A. D., Pattison J., Doniach D., Kennedy L. A., Batchelor J. R. Enhanced antibody responses in active chronic hepatitis: relation to HLA-B8 and HLA-B12 and porto-systemic shunting. Lancet. 1976 May 1;1(7966):930–934. doi: 10.1016/s0140-6736(76)92712-4. [DOI] [PubMed] [Google Scholar]
  10. Gilead Z., Jeng Y. H., Wold W. S., Sugawara K., Rho H. M., Harter M. L., Green M. Immunological identification of two adenovirus 2-induced early proteins possibly involved in cell transformation. Nature. 1976 Nov 18;264(5583):263–266. doi: 10.1038/264263a0. [DOI] [PubMed] [Google Scholar]
  11. Graves M. C., Silver S. M., Choppin P. W. Measles virus polypeptides synthesis in infected cells. Virology. 1978 May 1;86(1):254–263. doi: 10.1016/0042-6822(78)90025-9. [DOI] [PubMed] [Google Scholar]
  12. Hardwick J. M., Bussell R. H. Glycoproteins of measles virus under reducing and nonreducing conditions. J Virol. 1978 Feb;25(2):687–692. doi: 10.1128/jvi.25.2.687-692.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hollinger F. B., Sharp J. T., Lidsky M. D., Rawls W. E. Antibodies to viral antigens in systemic lupus erythematosus. Arthritis Rheum. 1971 Jan-Feb;14(1):1–11. doi: 10.1002/art.1780140102. [DOI] [PubMed] [Google Scholar]
  14. Kessler S. W. Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A. J Immunol. 1975 Dec;115(6):1617–1624. [PubMed] [Google Scholar]
  15. Kroll J. Line immunoelectrophoresis. Scand J Immunol Suppl. 1973;1:61–67. [PubMed] [Google Scholar]
  16. LAURELL C. B. ANTIGEN-ANTIBODY CROSSED ELECTROPHORESIS. Anal Biochem. 1965 Feb;10:358–361. doi: 10.1016/0003-2697(65)90278-2. [DOI] [PubMed] [Google Scholar]
  17. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  18. Laitinen O., Vesikari T., Vaheri A. Virus antibody levels in rheumatoid arthritis and systemic lupus erythematosus. Acta Med Scand. 1972 Jul-Aug;192(1-2):37–40. doi: 10.1111/j.0954-6820.1972.tb04775.x. [DOI] [PubMed] [Google Scholar]
  19. Lidman K., Biberfeld G., Sterner G., Norberg R. Chronic active hepatitis in children. A clinical and immunological long-term study. Acta Paediatr Scand. 1977 Jan;66(1):73–79. doi: 10.1111/j.1651-2227.1977.tb07810.x. [DOI] [PubMed] [Google Scholar]
  20. Lucas C. J., Brouwer R., Feltkamp T. E., ten Veen J. H., van Loghem J. J. Measles antibodies in sera from patients with autoimmune diseases. Lancet. 1972 Jan 15;1(7742):115–116. doi: 10.1016/s0140-6736(72)90679-4. [DOI] [PubMed] [Google Scholar]
  21. Lucas C. J., Ubels-Postma J. C., Rezee A., Galama J. M. Activation of measles virus from silently infected human lymphocytes. J Exp Med. 1978 Oct 1;148(4):940–952. doi: 10.1084/jem.148.4.940. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Mountcastle W. E., Choppin P. W. A comparison of the polypeptides of four measles virus strains. Virology. 1977 May 15;78(2):463–474. doi: 10.1016/0042-6822(77)90123-4. [DOI] [PubMed] [Google Scholar]
  23. Norrby E., Link H., Olsson J. E. Measles virus antibodies in multiple sclerosis. Comparison of antibody titers in cerebrospinal fluid and serum. Arch Neurol. 1974 Apr;30(4):285–292. doi: 10.1001/archneur.1974.00490340013002. [DOI] [PubMed] [Google Scholar]
  24. Norrild B., Bjerrum O. J., Vestergaard B. F. Polypeptide analysis of individual immunoprecipitates from crossed immunoelectrophoresis. Anal Biochem. 1977 Aug;81(2):432–441. doi: 10.1016/0003-2697(77)90714-x. [DOI] [PubMed] [Google Scholar]
  25. Payne F. E., Baublis J. V., Itabashi H. H. Isolation of measles virus from cell cultures of brain from a patient with subacute sclerosing panencephalitis. N Engl J Med. 1969 Sep 11;281(11):585–589. doi: 10.1056/NEJM196909112811103. [DOI] [PubMed] [Google Scholar]
  26. Reunanen M., Arstila P., Hakkarainen H., Nikoskelainen J., Salmi A., Panelius M. A longitudinal study on antibodies to measles and rubella viruses in patients with multiple sclerosis. A preliminary report. Acta Neurol Scand. 1976 Oct;54(4):366–370. doi: 10.1111/j.1600-0404.1976.tb04366.x. [DOI] [PubMed] [Google Scholar]
  27. Rima B. K., Martin S. J. Effect of undiluted passage on the polypeptides of measles virus. J Gen Virol. 1979 Jul;44(1):135–144. doi: 10.1099/0022-1317-44-1-135. [DOI] [PubMed] [Google Scholar]
  28. Robbins S. J., Bussell R. H., Rapp F. Isolation and partial characterization of two forms of cytoplasmic nucleocapsids from measles virus-infected cells. J Gen Virol. 1980 Apr;47(2):301–310. doi: 10.1099/0022-1317-47-2-301. [DOI] [PubMed] [Google Scholar]
  29. Robbins S. J., Bussell R. H. Structural phosphoproteins associated with purified measles virions and cytoplasmic nucleocapsids. Intervirology. 1979;12(2):96–102. doi: 10.1159/000149074. [DOI] [PubMed] [Google Scholar]
  30. Salmi A. A., Norrby E., Panelius M. Identification of different measles virus-specific antibodies in the serum and cerebrospinal fluid from patients with subacute sclerosing pancencephalitis and multiple sclerosis. Infect Immun. 1972 Sep;6(3):248–254. doi: 10.1128/iai.6.3.248-254.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Stallcup K. C., Wechsler S. L., Fields B. N. Purification of measles virus and characterization of subviral components. J Virol. 1979 Apr;30(1):166–176. doi: 10.1128/jvi.30.1.166-176.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Triger D. R. Bacterial, viral and auto antibodies in acute and chronic liver disease. Ann Clin Res. 1976 Jun;8(3):174–181. [PubMed] [Google Scholar]
  33. Triger D. R., MacCallum F. O., Kurtz J. B., Wright R. Raised antibody titres to measles and rubella viruses in chronic active hepatitis. Lancet. 1972 Mar 25;1(7752):665–667. doi: 10.1016/s0140-6736(72)90465-5. [DOI] [PubMed] [Google Scholar]
  34. Tyrrell D. L., Norrby E. Structural polypeptides of measles virus. J Gen Virol. 1978 May;39(2):219–229. doi: 10.1099/0022-1317-39-2-219. [DOI] [PubMed] [Google Scholar]
  35. Vainiopä R., Ziola B., Salmi A. Measles virus polypeptides in purified virions and in infected cells. Acta Pathol Microbiol Scand B. 1978 Dec;86B(6):379–385. doi: 10.1111/j.1699-0463.1978.tb00060.x. [DOI] [PubMed] [Google Scholar]
  36. Wechsler S. L., Fields B. N. Intracellular synthesis of measles virus-specified polypeptides. J Virol. 1978 Jan;25(1):285–297. doi: 10.1128/jvi.25.1.285-297.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Hygiene are provided here courtesy of Cambridge University Press

RESOURCES